These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 3080379)

  • 1. A comparison of the effects of combined or separate alpha- and beta-blockade in the treatment of hypertension in the acute stage of myocardial infarction.
    Renard M; Jacobs P; Liebens I; Abou Hamdam B; Bernard R
    Int J Cardiol; 1986 Feb; 10(2):149-58. PubMed ID: 3080379
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Labetalol infusion in acute myocardial infarction with systemic hypertension.
    Marx PG; Reid DS
    Br J Clin Pharmacol; 1979; 8(Suppl 2):233S-238S. PubMed ID: 526407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multiclinic comparison of labetalol to metoprolol in treatment of mild to moderate systemic hypertension.
    Frishman WH; Michelson EL; Johnson BF; Poland MP
    Am J Med; 1983 Oct; 75(4A):54-67. PubMed ID: 6356900
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Treatment of hypertension in acute stage of myocardial infarction. Haemodynamic effects of labetalol.
    Renard M; Rivière A; Jacobs P; Bernard R
    Br Heart J; 1983 Jun; 49(6):522-7. PubMed ID: 6849714
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sympathetic (alpha-beta) or calcium channel blockade for hypertensive myocardial infarction? A haemodynamic comparison of labetalol and nifedipine.
    Verma SP; Silke B; Hussain M; Nelson GI; Wilson JA; Reynolds GW; Richmond A; Taylor SH
    J Hypertens; 1988 Nov; 6(11):897-904. PubMed ID: 2906956
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hemodynamic and adrenergic effects of combined alpha/beta-receptor blockade versus combined beta-receptor and slow channel calcium blockade in patients with ischemic heart disease.
    Koch G; Fransson L
    Int J Cardiol; 1989 Oct; 25(1):73-9. PubMed ID: 2793265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of labetalol on preload in acute myocardial infarction with systemic hypertension.
    Renard M; Jacobs P; Melot C; Haardt R; Vainsel H; Bernard R
    J Cardiovasc Pharmacol; 1984; 6(1):90-3. PubMed ID: 6199618
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hemodynamic effects at rest and during exercise of combined alpha/beta-receptor blockade and of beta-receptor blockade alone in patients with ischemic heart disease.
    Koch G; Fransson L
    J Cardiovasc Pharmacol; 1987 Oct; 10(4):474-8. PubMed ID: 2444802
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Acute effects of combined alpha/beta-adrenoceptor blockade v combined beta-receptor and slow channel calcium blockade in ischemic heart disease complicated by hypertension. Hemodynamic and adrenergic responses.
    Koch G; Fransson L
    Am J Hypertens; 1991 Aug; 4(8):709-13. PubMed ID: 1681821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-response evaluation of oral labetalol in patients presenting to the emergency department with accelerated hypertension.
    Gonzalez ER; Peterson MA; Racht EM; Ornato JP; Due DL
    Ann Emerg Med; 1991 Apr; 20(4):333-8. PubMed ID: 2003657
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Haemodynamic dose-response effects of intravenous labetalol in acute myocardial infarction.
    Nelson GI; Silke B; Ahuja RC; Hussain M; Taylor SH
    Postgrad Med J; 1983; 59 Suppl 3():98-103. PubMed ID: 6647215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The anti-hypertensive efficacy of combined alpha- and beta-adrenoreceptor blockade with phentolamine-oxprenolol or with labetalol (AH 5158).
    Johnson BF; LaBrooy J; Munro-Faure AD
    Clin Sci Mol Med Suppl; 1976 Dec; 3():505s-507s. PubMed ID: 799558
    [TBL] [Abstract][Full Text] [Related]  

  • 13. alpha- and beta-blockade with labetalol in acute myocardial infarction.
    Nelson GI; Ahuja RC; Hussain M; Silke B; Taylor SH
    J Cardiovasc Pharmacol; 1982; 4(6):921-4. PubMed ID: 6185783
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Central haemodynamics in acute myocardial infarction. Natural history, relation to enzyme release and effects of metoprolol.
    Held P
    Acta Med Scand Suppl; 1986; 709():1-47. PubMed ID: 3532697
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combined alpha- and beta-receptor inhibition in the treatment of hypertension.
    Prichard BN
    Drugs; 1984; 28 Suppl 2():51-68. PubMed ID: 6151891
    [TBL] [Abstract][Full Text] [Related]  

  • 16. On the combination of alpha- and beta-adrenoceptor blockade in hypertension.
    Stokes GS; Mennie BA; Gellatly R; Hill A
    Clin Pharmacol Ther; 1983 Nov; 34(5):576-82. PubMed ID: 6627819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Labetalol for the control of elevated blood pressure following coronary artery bypass grafting.
    Sladen RN; Klamerus KJ; Swafford MW; Prough DS; Mann HJ; Leslie JB; Goldberg JS; Levitsky S; Molina JE; Mills SA
    J Cardiothorac Anesth; 1990 Apr; 4(2):210-21. PubMed ID: 2131869
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparative anti-hypertensive effects of labetalol and the combination of oxprenolol and phentolamine.
    Johnson BF; LaBrooy J; Munro-Faure AD
    Br J Clin Pharmacol; 1976 Aug; 3(4 Suppl 3):783-7. PubMed ID: 791332
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Beta-adrenergic blockade in acute myocardial infarction: a haemodynamic and radionuclide study.
    Murray DP; Murray RG; Rafiqi E; Littler WA
    Eur Heart J; 1987 Aug; 8(8):845-54. PubMed ID: 3311755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Propranolol vs metoprolol vs labetalol: a comparative study in essential hypertension.
    Kubik MM; Coote JH
    Eur J Clin Pharmacol; 1984; 26(1):1-6. PubMed ID: 6143666
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.